Transcatheter heart valves technologies

Gender-related differences on outcome following transcatheter mitral valve repair (TMVR): a systematic review and meta-analysis

Published on 02/03/2023 | Yi Kang 1 et al. | Journal of Cardiothoracic Surgery 2023; 18(1): 31 | 20 minute read

Abstract Background The effect of gender on patients with mitral valve regurgitation (MR) undergoing transcatheter mitral valve repair (TMVR) remains

Transcatheter heart valves technologies

Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease

Published on 16/02/2023 | Hector A. Alvarez‐CovarrubiasMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30576 | 20 minute read

Abstract Objectives To investigate the feasibility and safety of percutaneous transluminal angioplasty (PTA) of the iliofemoral arteries (IFA) before transfemoral

Transcatheter heart valves technologies

Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques

Published on 16/02/2023 | Tarantini et al. | The American Journal of Cardiology 2023; aop:10.1016/j.amjcard.2023.01.010 | 0 minute read

Transcatheter heart valves technologies

Short- to mid-term outcomes after transcatheter aortic valve replacement in patients with ascending aorta dilation: a single-centre retrospective analysis

Published on 02/02/2023 | Yu Jun et al. | BMC Cardiovascular Disorders 2023; 23(1): 31 | 18 minute read

Abstract Objectives Ascending aorta dilation (AAD) is frequently associated with aortic stenosis (AS). This study investigated the procedural and clinical

Transcatheter heart valves technologies

Peri‐procedural management of transcatheter mitral valve replacement in patients with heart failure

Published on 19/01/2023 | Sara L.Hungerford 1 et al. | European Journal of Heart Failure 2022; AOP: 10.1002/ejhf.2758 | 34 minute read

Abstract Over the past decade, transcatheter mitral valve replacement (TMVR) technologies have evolved with the objective of improving outcomes for

Transcatheter heart valves technologies

Minimum-incision trans-subclavian transcatheter aortic valve replacement with regional anesthesia

Published on 19/01/2023 | Domoto et al. | Journal of Cardiology 2023; 81(2): 131-7 | 0 minute read

Transcatheter heart valves technologies

Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis

Published on 05/01/2023 | Isabel A. Hoerbrand 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.14262 | 21 minute read

Abstract Aims Wildtype transthyretin amyloid cardiomyopathy is an under‐recognized cause of heart failure in elderly patients. Transcatheter tricuspid valve repair

Transcatheter heart valves technologies

Multicenter experience with valve‐in‐valve transcatheter aortic valve replacement compared with primary, native valve transcatheter aortic valve replacement

Published on 15/12/2022 | Michael P. RobichMD 1 et al. | Journal of Cardiac Surgery 2022; AOP: 10.1111/jocs.17084 | 16 minute read

Abstract Background Valve‐in‐valve (ViV) transcatheter aortic valve replacement (TAVR) offers an alternative to reoperative surgical aortic valve replacement. The short‐

Transcatheter heart valves technologies

2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses

Published on 15/12/2022 | Eleid et al. | Journal of the American College of Cardiology 2022; 80(23): 2171-83 | 0 minute read

Transcatheter heart valves technologies

Treatment in patients with severe asymptomatic aortic stenosis: is it best not to wait?

Published on 01/12/2022 | Elena Di Pietro et al. | European Heart Journal Supplement 2022; 24(Supplement_I): I170 | 13 minute read

Abstract New insights into the natural history and pathophysiology of patients with aortic stenosis (AS), coupled with the dramatic evolution

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.